Cargando…
Circulating tissue inhibitor of metalloproteinases 1 (TIMP-1) at COVID-19 onset predicts severity status
BACKGROUND: Systemic biomarkers for severity of SARS-CoV-2 infection are of great interest. In this study, we evaluated a set of collagen metabolites and extracellular matrix remodeling biomarkers including procollagen type III amino terminal propeptide (PIIINP), tissue inhibitor of metalloproteinas...
Autores principales: | Brusa, Stefano, Terracciano, Daniela, Bruzzese, Dario, Fiorenza, Mariano, Stanziola, Lucia, Pinchera, Biagio, Valente, Valeria, Gentile, Ivan, Cittadini, Antonio, Mormile, Ilaria, Mormile, Mauro, Portella, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744795/ https://www.ncbi.nlm.nih.gov/pubmed/36523781 http://dx.doi.org/10.3389/fmed.2022.1034288 |
Ejemplares similares
-
Matrix metalloproteinases (MMP) 3 and 9 as biomarkers of severity in COVID-19 patients
por: Gelzo, Monica, et al.
Publicado: (2022) -
Prognostic Role of Neutrophil to Lymphocyte Ratio in COVID-19 Patients: Still Valid in Patients That Had Started Therapy?
por: Gelzo, Monica, et al.
Publicado: (2021) -
Venous thromboembolism and lung cancer: a review
por: Vitale, Carolina, et al.
Publicado: (2015) -
Effects of combination therapy indacaterol/glycopyrronium versus tiotropium on moderate to severe COPD: evaluation of impulse oscillometry and exacerbation rate
por: Molino, Antonio, et al.
Publicado: (2017) -
Differential effects of tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 on atherosclerosis and monocyte/macrophage invasion
por: Di Gregoli, Karina, et al.
Publicado: (2016)